
Linda K Hendricks MD
Myeloproliferative Disorder Hematology-Oncology
Physician
Join to View Full Profile
800 1st StSuite 410Macon, GA 31201
Phone+1 478-743-7068
Fax+1 478-741-1354
Dr. Hendricks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of GeorgiaFellowship, Hematology and Medical Oncology, 1998 - 2000
Medical College of GeorgiaResidency, Internal Medicine, 1995 - 1998
Medical College of Georgia at Augusta UniversityClass of 1995
Certifications & Licensure
GA State Medical License 1997 - 2027
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology
Clinical Trials
- IORT-Breast at Medical Center Navicent Health Start of enrollment: 2019 Mar 19
Publications & Presentations
PubMed
- 8 citationsA Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast CancerDenise A. Yardley, N. W. Peacock, Natalie R. Dickson, Melissa B. White, Elizabeth R. Vazquez
Clinical Breast Cancer. 2010-06-01 - 18 citationsMultiple Myeloma Associated with Lactic AcidosisCelalettin Ustun, Pamela J. Fall, Harold M. Szerlip, Anand Jillella, Linda Hendricks
Leukemia & Lymphoma. 2002-12-01 - 10 citationsAssociation of breast cancer and immune thrombocytopenic purpura.Celalettin Ustun, Paul M. Dainer, Linda Hendricks, Charles Todd Bruker, Russell Burgess
Southern Medical Journal. 2002-11-01
Press Mentions
Deadly Ovarian Cancer Is Very Hard to Detect, so Women Need to Stay VigilantSeptember 26th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









